We have recently (7) described a method that utilizes the isolated, perfused dog brain and an indicator dilution-technique to study unidirectional transport kinetics under various conditions (5-7). The current study utilizes the indicator-dilution method to describe some of the properties of L-leucine transport between blood and brain. Others have shown that L-leucine enters the brain by means of a saturable transport system (3, 24, 28-30, 33, 36 ) that can be inhibited by L-isoleucine (36) and L-valine (3, 33) . Our experiments describe the kinetics of unidirectional leucine transport, and its inhibition by L-isoleucine and L-valine, as well as the effect of anoxia on L-leucine transport.
Part of this work was presented in a preliminary communication (2 1). The isotope mixture was injected directly into the blood stream through a rubber injection port located about 4 cm before the bifurcation of the common carotid artery. Except in the anoxic experiments, injections were made 20 s after the switching of perfusion from the control pump to the experimental pump. This procedure minimized the possibility of product inhibition of transport resulting from the elevation of cerebral amino acid levels during perfusion with blood having a high L-leucine, L-isoleucine, or L-valine concentration.
Beginning 3 s after the injection, 30 consecutive venous blood samples were collected at l-s intervals. Immediately after the 30th sample, the blood flow rate was determined by measuring the volume of a 1-min collection of venous blood. A sample of this venous blood was saved for determination of the venous amino acid content while the corresponding arterial sample was taken directly from the oxygenator. Between 6 and 12 separate indicator-dilution injections were made with each isolated brain.
Prior to simultaneous liquid scintillation counting of YNa and "H, the individual indicator-dilution blood samples were digested and decolorized by the H202-HC103 method described previously (7). The arterial and venous amino acid content was determined in picric acid-deproteinized plasma samples with a Beckman Spinco model 12OC amino acid analyzer (4).
The data treatment for each indicator-dilution injection (7) permitted calculation of the maximal fractional extraction, E, for L-leucine.
The rate of unidirectional L-leucine transport into the brain, u, was calculated from the equation z, = EALeUFp/W, in which Azeu is the arterial plasma L-leutine concentration, Fr is the plasma flow rate, and W is the brain weight.
Prior to the end of an experiment, Fp/W could only be estimated since W was unknown. Therefore, the pump speed was adjusted to maintain the estimated Fp/W between 0.40 and 0.50 ml/g per min (7). The average (GE) Fp/W calculated f rom postmortem brain weights was 0.460 & -006 (n = 108).
Ex;herimental groups* Seventeen isolated brains were used in the experiments designed to determine the kinetics of unidirectional L-leucine transport and its inhibition by L-isoleucine and L-valine. Indicator-dilution injections were made over a range of plasma L-leucine concentrations between 0.160 and 6.15 mM and at various fixed levels of L-valine (0.172-3.77 mM) and L-isoleucine (0.052-4.16 mM) .
Four isolated brains were used to test the effects of anoxia on L-leucine transport. similar to that utilized
The experimental procedure to study glucose transport du was ring anoxia (6). The Paz of the blood in the experimental oxygenator was reduced to less than 10 xnmHg. The plasma L-leucine, L-valine, and L-isoleucine concentrations were allowed to remain at control levels (Table 2) . Two indica- tor-dilu tion injections we re made during perfusion of each isolated brain with blood from the control oxygena tor. The
In order to determine the kinetic constants for L-leucine transport at any level of the other two amino acids, we used an equation (12) which describes Michaelis-Menten kinetics in the presence of two competitive inhibitors, equavalve was then switched and the brain was perfused with the anoxic blood. Indicator-dilution injections were made after 1, 5, and 10 rnin of anoxia, the valve was switched back, and the brain was again perfused with the control blood. The injections were repeated after 10, 20, 30, and 60 min of recovery from 10 min of anoxia. it is impossible either to elim inate a constituent or to con trol i ts concen tra .tion fron 1 one preparation to the next. It is well established that L-leucine transport into brain is inhibited by certain other amino acids (3, 28, 30, 33, 36) . Therefore, we found it necessary to fit our data to an equation that would take variations in the concentrations of other amino acids into account.
To simplify the analysis, we assumed that L-isoleucine and L-valine would be the major inhibiting amino acids and that transport of the branched-chain neutral amino acids could be described by Michaelis-Menten kinetics, i. Although the increase in the rate of tran szlort d uring and after apparent anoxia 1s not statistically significant (Table  Z) , it should be noted that the average arterial L-leucine concentration during control perfusion is lower than during anoxic and postanoxic perfusion. This is due to cerebral L-leucine metabolism during the precon trol maintenance period.
where A, the average of the arterial and venous amino acid levels, is used as an estimate of their concentration in the capillary.
to determine the type of inhibition that L-isoleucine ( Fig. 1) A preliminary analysis of the data was performed in order and L-valine (Fig. 2) would exert on L-leucinc transport.
Since example, in the Ehrlich cells, the L system has a Km for Lleucine of 0.5 mM and is Na independent (32). A similar system in the human erythrocyte has a K, for L-leucine of 1.8 mM (34).
The technique used in this study is a modification of the method first developed by Chinard et al. (9) and later adapted for use in the canine brain by Crone (13) and Yudilevich and DeRose (35) . We have previously presented the details of our modifications of this procedure (7). Briefly, they include use of the maximal observed E as the E for the whole brain (2). 22Na as the intravascular reference (35), and a smaller injectate volume. Furthermore, because of the ability to adjust and measure the perfusate composition and flow rate, use of the isolated perfused brain permits a direct determination of transport kinetics under a wide variety of conditions.
In our previous study of unidirectional glucose transport, we found it necessary to use a factor of 3.6 %;1 to correct for simple diffusion of glucose into the brain (7). This figure was determined from indicator-dilution experiments with a hexose that is not transported into brain (D-fructose). Because of the lack of structural similarity between hexoses and amino acids, it is not reasonable to apply this same correction to the L-leucine data. Initial studies to determine whether the maximal fractional extraction value, E, for D-leucine would be a suitable diffusion correction showed that D-leucine is itself transported into the brain and that it can inhibit L-leucine transport (unpublished results) -Sixnilar results have been obtained by other investigators (25, 26, 30) . The arbitrary introduction of even a 1 c/c: diffusion correction into our data resulted in a substantial increase in the SE's for the kinetic constants.
In addition, Hoare (23) has shown that L-leucine diffusion into human erythrocytes is insignificant at 37°C. Consequently, we did not use a diffusion correction in this study.
Christensen (10) states that if one substrate (A) competes with the transport of a second substrate (B), and both are transported by a single '<agency," then the Ki,, determined from inhibition of A against B is equal to the Km,. determined directIy.
The involvement of a single system in cerebral L-leucine, L-isoleucine, and L-valine transport is suggested by the linearity of the plots in Figs. 1 and 2 . Support for this proposition is found in the work of Yudilevich et al. (36) who showed that unidirectional extraction of r,-valine could be eliminated by high levels of L-leucine, while L-leucine extraction was abolished by high concentrations of L-phenylalanine and L-tryptophan. The fact that L-phenylalanine extraction was only halved in the presence of high L-leucine levels suggests that L-phenylalanine has affinity for more than one transport system. If there is only one system with af-finity for large neutral amino acids, then the Ki's for L-isoleucine and L-valine are identical to their respective K$s-It must be remembered, however, that the values presented are apparent Km's, which are valid only when the concentrations of all other inhibitors are similar to those in this study. Figure 3 shows a comparison of the K,'s for these three amino acids with their respective average concentrations in canine plasma. For all three compounds, the average plasma concentration is about 20 % of the corresponding K,. This suggests that at average plasma concentrations unidirectional transport into the brain is nearly a firstorder process. In a study of the effects of sodium pentobarbital on the net uptake of amino acids in the isolated dog brain (4), we observed a constant and highly significant uptake of L-Ieucine and L-isoleucine. This observation was subsequently confirmed in the human brain (17). We suggested that these amino acids play an important role in cerebral metabolism.
However 
